Vivasc Therapeutics
Vivasc Therapeutics is an early stage, pre-clinical cardiac drug development company. We are utilizing the proprietary Cardiac Targeting Peptide (CTP) platform technology to deliver various cargo exclusively to cardiomyocytes in a non-invasive manner. We are actively seeking: Joint development partners for our lead compound, CTP-amio, for the treatment of arrhythmias (atrial fibrillation and ventricular tachycardia) Partners to use CTP as a platform vector to deliver other therapeutic cargo (oligonucleotides, peptides, proteins, drugs, nanoparticles, stem cell therapies, etc.) exclusively to cardiomyocytes
Vivasc Therapeutics
Vivasc Therapeutics is an early stage, pre-clinical cardiac drug development company. We are utilizing the proprietary Cardiac Targeting Peptide (CTP) platform technology to deliver various cargo exclusively to cardiomyocytes in a non-invasive manner. We are actively seeking: Joint development partners for our lead compound, CTP-amio, for the treatment of arrhythmias (atrial fibrillation and ventricular tachycardia) Partners to use CTP as a platform vector to deliver other therapeutic cargo (oligonucleotides, peptides, proteins, drugs, nanoparticles, stem cell therapies, etc.) exclusively to cardiomyocytes
vivasctherapeutics.com
2403 Sidney St Suite 255 Pittsburgh, Pennsylvania 15203, US
Details
Year founded
2019
Revenue
1M-5M
Employees
1-10
Number of locations
1
NAICS
3254
SIC
2834
Products & Services
Outlines the company's specialized services and operational strengths.
- Atrial fibrillation (AFib)
- Cardiac Targeting Peptide (CTP) platform
- Cardiology
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- Cardiac Targeting Peptide (CTP) platform technology
- CTP conjugates
- Cardiac Targeting Peptide-cyanine 5.5-N-Hydroxysuccinimide (CTP)
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
FALSE
Our production algorithm is showing that vivasc therapeutics is not ramping up production.
Target industries
Locations (1)
Vivasc Therapeutics
2403 Sidney St Suite 255 Pittsburgh, Pennsylvania 15203, US
People Also Searched For
Frequently Asked Questions
What services & capabilities does Vivasc Therapeutics offer?
Vivasc Therapeutics offers a range of services and capabilities, including Atrial fibrillation (AFib).
What kind of equipment does Vivasc Therapeutics use?
Vivasc Therapeutics uses a variety of equipment, including Cardiac Targeting Peptide (CTP) platform technology.
What are the target industries of Vivasc Therapeutics?
Vivasc Therapeutics serves several industries, including the medical industry.
How many locations does Vivasc Therapeutics operate?
Vivasc Therapeutics operates from a single location at 2403 sidney street suite 255, pittsburgh, pennsylvania 15203, united states.
Where are the headquarters of Vivasc Therapeutics?
The headquarters of Vivasc Therapeutics are located in 2403 sidney street suite 255, pittsburgh, pennsylvania 15203, united states.
What is the NAICS code for Vivasc Therapeutics?
The NAICS code for Vivasc Therapeutics is 3254.
How many employees does Vivasc Therapeutics have?
Vivasc Therapeutics has an employee count in the range of 1-10 employees.
What is the official website of Vivasc Therapeutics?
The official website of Vivasc Therapeutics is https://vivasctherapeutics.com/.
When was Vivasc Therapeutics founded?
Vivasc Therapeutics was founded in 2019.